Current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 STI treatment guidance. Although the guidelines emphasize treatment, prevention strategies and diagnostic recommendations also are discussed.
Current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 STI treatment guidance. Although the guidelines emphasize treatment, prevention strategies and diagnostic recommendations also are discussed.
Home
Training STD Expert Hour Webinar – New Frontiers in STI/HIV Prevention and Family Planning: The promise of Multipurpose Prevention Technologies
STD Expert Hour Webinar – New Frontiers in STI/HIV Prevention and Family Planning: The promise of Multipurpose Prevention Technologies
Wednesday, June 23, 2021
Presented by Bethany Young Holt, PhD, MPH
Learn about the latest developments in the field of Multipurpose Prevention Technologies (MPTs), products that provide contraception along with protection from STIs and/or HIV.
The origins of MPTs and the current research/development pipeline will also be discussed.
Learning Objectives:
Provide evidence of the need for products that simultaneously address multiple health risks, such as HIV, other STIs, and unplanned pregnancy
Introduce and implement Multipurpose Prevention Technologies (MPTs) and the product candidates currently in development for prevention of HIV, other STIs and/or unintended pregnancies
Describe the Initiative for MPTs (IMPT) and its publicly-available tools for tracking the MPT product development pipeline, while summarizing the current pipeline profile, recent scientific breakthroughs, and the potential impact of MPTs for women around the world
Outline next steps for key stakeholders in STI prevention and related health fields, with a focus on tangible priority actions that will help bring MPTs to the hands of end-users
California Clinical Guidelines for Gonorrhea Treatment and Management of Suspected Treatment Failure
This guideline summarizes the California Department of Public Health (CDPH) clinical recommendations to enhance detection and management of suspected gonorrhea treatment failure and assure adequate treatment.
Home
Training STD Clinical Update Webinar – Congenital Syphilis Update for CA Pediatric Providers
STD Clinical Update Webinar – Congenital Syphilis Update for CA Pediatric Providers
May 25, 2021
The California Department of Public Health (CDPH) continues to see dramatic statewide increases in cases of congenital syphilis (CS), a severe yet preventable condition when syphilis is passed from mother to fetus.
This webinar, presented by the California Prevention Training Center, features Dr. Kelly Johnson, infectious disease physician from UCSF and Dr. Nael Mhaissen, pediatric infectious diseases specialist from Valley Children’s Hospital.
They will discuss CS epidemiology, clinical presentation, and neonatal management. Finally, they will discuss ways providers can help stem the rising tide of CS.
Drs. Mhaissen and Johnson cover the following learning objectives for this webinar:
Describe California’s CS epidemiology
Recognize the clinical manifestations of CS
Discuss CS diagnosis, evaluation, and management
Report all laboratory-confirmed and clinically-suspected cases of CS to public health
Gonorrhea 2020 CDC Treatment Update
This guideline summarizes the California Department of Public Health (CDPH) clinical recommendations to enhance detection and management of suspected gonorrhea treatment failure and assure adequate treatment.
Disseminated Gonococcal Infection in CA—Dear Colleague letter from CDPH
December 23, 2020: CDPH requests medical providers should reinstate routine screening recommendations for STDs in females <25 years of age, pregnant females, men who have sex with men and individuals with HIV. Providers should increase their clinical suspicion for DGI in patients with joint pain and undertake the following additional actions.
The California Department of Public Health (CDPH) has received increasing reports of disseminated gonococcal infection (DGI), a severe complication of untreated gonorrhea. Dr. Laura Quilter and Dr. Eric Tang discuss DGI epidemiology, clinical presentation, and management, and review California’s recent DGI investigation and what clinicians can do to help.
Drs. Quilter and Tang cover the following learning objectives for this webinar:
Describe the epidemiology of uncomplicated gonorrhea and DGI
Recognize the clinical manifestations of DGI and increase clinical suspicion for DGI in patients with joint pain
Demonstrate how to diagnose, manage, and treat DGI
Report all laboratory-confirmed and clinically-suspected cases of DGI to public health
Prioritize routine screening, testing, and treatment of STDs among high-risk patients
STD Clinical Consultation Network App
STD Clinical Toolbox: A free app for medical professionals nationwide. From the National Network of STD Clinical Prevention Training Centers.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.AcceptDisable